...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: ZHCLF

NBB,,,,,you imagine if ZEN does get taken out!!,,,,,,our old silverback in Calgary would be pounding his chest and we would never be free from his incompentence in the sister company,,,,never!,,,we shareholders are in a handmaids tale!

Share
New Message
Please login to post a reply